Melanotransferrin/CD228/MFI2 Antibody (893416) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # FAB81751L
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 893416
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 human embryonic kidney cell line transfected with human Melanotransferrin/CD228
Gly20-Gly711
Accession # P08582
Gly20-Gly711
Accession # P08582
Specificity
Detects human Melanotransferrin/CD228 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Melanotransferrin/CD228/MFI2 Antibody (893416) [DyLight 550]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Melanotransferrin/CD228
Alternate Names
CD228, MAP97, MFI2, MTF, p97
Gene Symbol
MFI2
Additional Melanotransferrin/CD228 Products
Product Documents for Melanotransferrin/CD228/MFI2 Antibody (893416) [DyLight 550]
Product Specific Notices for Melanotransferrin/CD228/MFI2 Antibody (893416) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...